Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$13.07
0.473.73%
Last update: Oct 9, 7:54 PM
$13.03
0.433.41%
Intellia Therapeutics Inc (NTLA) Stock Price, Quote, News & History
NTLANASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Intellia Therapeutics (NASDAQ:NTLA) through any online brokerage.
Other companies in Intellia Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Intellia Therapeutics has a consensus price target of $24.69.
The stock price for Intellia Therapeutics (NASDAQ: NTLA) is $13.03 last updated October 9, 2026 at 7:54 PM EDT.
There are no upcoming dividends for Intellia Therapeutics.
Intellia Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Intellia Therapeutics.
Intellia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
